Dr. Christopher Shade
Dr. Christopher Shade, PhD, founder and CEO of Quicksilver Scientific, continues to be the driving force of development and innovation. Dr. Shade’s vast depth and breadth of knowledge, passion for healing, and intuitive understanding of chemistry and biology are reflected in Quicksilver Scientific’s well-designed detoxification protocols, unique supplement delivery systems, and patented mercury speciation test.
Dr. Shade is a recognized expert on mercury and liposomal delivery systems. He has lectured and trained doctors in the U.S. and internationally on the subject of mercury, heavy metals, and the human detoxification system. Dr. Shade developed the patented liquid chromatographic mercury speciation technology used at Quicksilver Scientific while conducting his PhD dissertation work with advisor Robert Hudson at the University of Illinois at Urbana-Champaign. This technology was used to create the Mercury Tri-Test.
Dr. Shade’s current focus is on the development of cutting-edge, lipid-based delivery systems for nutraceuticals, such as liposomes and micro-emulsion systems, to address the growing need of high quality, affordable detoxification solutions.